In last trading session, Hoth Therapeutics Inc (NASDAQ:HOTH) saw 63.65 million shares changing hands with its beta currently measuring 0.65. Company’s recent per share price level of $1.90 trading at -$0.38 or -16.67% at ring of the bell on the day assigns it a market valuation of $13.12M. That closing price of HOTH’s stock is at a discount of -100.0% from its 52-week high price of $3.80 and is indicating a premium of 69.47% from its 52-week low price of $0.58. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 49.19 million shares which gives us an average trading volume of 7.74 million if we extend that period to 3-months.
For Hoth Therapeutics Inc (HOTH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Upright in the red during last session for losing -16.67%, in the last five days HOTH remained trading in the green while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $1.90 price level, adding 50.0% to its value on the day. Hoth Therapeutics Inc’s shares saw a change of 153.98% in year-to-date performance and have moved 153.98% in past 5-day. Hoth Therapeutics Inc (NASDAQ:HOTH) showed a performance of 127.11% in past 30-days. Number of shares sold short was 0.29 million shares which calculate 0.26 days to cover the short interests.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Statistics highlight that Hoth Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 107.22% of value to its shares in past 6 months, showing an annual growth rate of 48.70% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 15.18% during past 5 years.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Insiders are in possession of 0.92% of company’s total shares while institution are holding 5.31 percent of that, with stock having share float percentage of 5.36%. Investors also watch the number of corporate investors in a company very closely, which is 5.31% institutions for Hoth Therapeutics Inc that are currently holding shares of the company.
